Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 16 Source: CRO
- €377.3 million turnover
-
€0.1 million
profit - 236 employees
-
31st Dec 15 Source: CRO
- €241.5 million turnover
-
€0.2 million
profit - 158 employees
- 1 more year available »
Ranking
By Turnover
(€377.3 million)- 191st in Top Companies
- 26th in Health
By Employees
(236)- 533rd in Top Companies
- 72nd in Health
- 236
- €377.3 million
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- 6:07pm Kingfisher quits Russia, Spain and Portugal as French sales tumble
- 6:01pm Nissan seeks more sway in Renault alliance as governments urge stability
- 5:27pm Sweden’s push to get rid of cash has some saying, ‘not so fast’
- 4:45pm Grant Thornton in spotlight over Patisserie Valerie
- 4:12pm Bet365 chief was paid £220m last year